In this study, we examined the expression of LMP2, PSME1, and PSME2 in pre-treatment NACI-NSCLC tumor tissue specimens and explored their prognostic value in patients with NACI-NSCLC. The gene discussed is PSME2; the disease is non-small cell lung carcinoma.